{"id":"https://openalex.org/W2398865192","doi":null,"title":"[Challenges and strategies of drug innovation].","display_name":"[Challenges and strategies of drug innovation].","alternate_titles":[],"publication_year":2013,"publication_date":"2013-07-01","ids":{"openalex":"https://openalex.org/W2398865192","mag":"2398865192","pmid":"https://pubmed.ncbi.nlm.nih.gov/24133969"},"language":"zh","primary_location":{"id":"pmid:24133969","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24133969","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Yao xue xue bao = Acta pharmaceutica Sinica","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W2398865192"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101014268","display_name":"Zongru Guo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200296433","display_name":"Chinese Academy of Medical Sciences & Peking Union Medical College","ror":"https://ror.org/02drdmm93","country_code":"CN","type":"education","lineage":["https://openalex.org/I200296433"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Zong-Ru Guo","raw_affiliation_strings":["Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China. zrguo@imm.ac.cn","Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China. zrguo@imm.ac.cn","institution_ids":["https://openalex.org/I200296433"]},{"raw_affiliation_string":"Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China","institution_ids":["https://openalex.org/I200296433"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5000984914","display_name":"Hongyu Zhao","orcid":"https://orcid.org/0000-0002-8999-3285","observed_orcids":["https://orcid.org/0000-0002-8999-3285","https://orcid.org/0000-0002-2737-9570"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hong-Yu Zhao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":92},"biblio":{"volume":"48","issue":"7","first_page":"1031","last_page":"1040"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.8036999702453613,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.8036999702453613,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.1143999993801117,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13656","display_name":"Science, Research, and Medicine","score":0.0203000009059906,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pharmaceutical-innovation","display_name":"pharmaceutical innovation","score":0.9810000061988831},{"id":"https://openalex.org/keywords/drug-discovery","display_name":"drug discovery","score":0.9340000152587891},{"id":"https://openalex.org/keywords/drug-development-strategy","display_name":"drug development strategy","score":0.5740000009536743},{"id":"https://openalex.org/keywords/contract-research-organizations","display_name":"contract research organizations","score":0.6779999732971191},{"id":"https://openalex.org/keywords/orphan-drugs","display_name":"orphan drugs","score":0.5099999904632568},{"id":"https://openalex.org/keywords/covalent-ligands","display_name":"covalent ligands","score":0.8790000081062317},{"id":"https://openalex.org/keywords/prodrugs","display_name":"prodrugs","score":0.9940000176429749},{"id":"https://openalex.org/keywords/blockbuster-drugs","display_name":"blockbuster drugs","score":0.5559999942779541},{"id":"https://openalex.org/keywords/injectable-drugs","display_name":"injectable drugs","score":0.6909999847412109}],"concepts":[{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.6514488458633423},{"id":"https://openalex.org/C2778137410","wikidata":"https://www.wikidata.org/wiki/Q2732820","display_name":"Government (linguistics)","level":2,"score":0.5200521349906921},{"id":"https://openalex.org/C58546491","wikidata":"https://www.wikidata.org/wiki/Q1150207","display_name":"Competitive advantage","level":2,"score":0.4552813768386841},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.44663119316101074},{"id":"https://openalex.org/C2119116","wikidata":"https://www.wikidata.org/wiki/Q7181","display_name":"Globalization","level":2,"score":0.4448862373828888},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.4431381821632385},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.4155597388744354},{"id":"https://openalex.org/C191935318","wikidata":"https://www.wikidata.org/wiki/Q148","display_name":"China","level":2,"score":0.41296079754829407},{"id":"https://openalex.org/C40700","wikidata":"https://www.wikidata.org/wiki/Q1411783","display_name":"Industrial organization","level":1,"score":0.3995743691921234},{"id":"https://openalex.org/C2522767166","wikidata":"https://www.wikidata.org/wiki/Q2374463","display_name":"Data science","level":1,"score":0.3919517397880554},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.3730441629886627},{"id":"https://openalex.org/C162853370","wikidata":"https://www.wikidata.org/wiki/Q39809","display_name":"Marketing","level":1,"score":0.29184895753860474},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.26656025648117065},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.2647140622138977},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.12090116739273071},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.10821956396102905},{"id":"https://openalex.org/C41895202","wikidata":"https://www.wikidata.org/wiki/Q8162","display_name":"Linguistics","level":1,"score":0.0},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C34447519","wikidata":"https://www.wikidata.org/wiki/Q179522","display_name":"Market economy","level":1,"score":0.0},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.0},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000047","descriptor_name":"Academies and Institutes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002681","descriptor_name":"China","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007221","descriptor_name":"Industry","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D007449","descriptor_name":"Investments","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D009965","descriptor_name":"Orphan Drug Production","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016527","descriptor_name":"Drug Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D035843","descriptor_name":"Biomedical Research","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D055818","descriptor_name":"Public-Private Sector Partnerships","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:24133969","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24133969","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Yao xue xue bao = Acta pharmaceutica Sinica","raw_type":"Journal Article"},{"id":"mag:2398865192","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24133969","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.4943999946117401,"id":"https://metadata.un.org/sdg/9","display_name":"Industry, innovation and infrastructure"},{"score":0.428600013256073,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":18,"referenced_works":["https://openalex.org/W104342353","https://openalex.org/W1976159554","https://openalex.org/W1978336812","https://openalex.org/W1984531810","https://openalex.org/W1987777080","https://openalex.org/W1995356700","https://openalex.org/W2007924060","https://openalex.org/W2010993054","https://openalex.org/W2015474901","https://openalex.org/W2040860367","https://openalex.org/W2052214665","https://openalex.org/W2067833766","https://openalex.org/W2069249852","https://openalex.org/W2084084945","https://openalex.org/W2088294577","https://openalex.org/W2099905447","https://openalex.org/W2162294150","https://openalex.org/W2461191077"],"related_works":["https://openalex.org/W1985929899","https://openalex.org/W2268603451","https://openalex.org/W2387186406","https://openalex.org/W2347650013","https://openalex.org/W4221054384","https://openalex.org/W2152093043","https://openalex.org/W1846371116","https://openalex.org/W6960229507","https://openalex.org/W3036422833","https://openalex.org/W7037371505"],"abstract_inverted_index":{"Drug":[0,111],"research":[1,136,251],"involves":[2],"scientific":[3],"discovery,":[4],"technological":[5,120,199],"inventions":[6],"and":[7,18,21,45,100,122,125,137,188,235,242,262,293],"product":[8],"development.":[9,110],"This":[10,286],"multiple":[11,81],"dimensional":[12],"effort":[13],"embodies":[14],"both":[15,116],"high":[16,19,264],"risk":[17,61],"reward":[20],"is":[22,113,141,190],"considered":[23],"one":[24],"of":[25,35,41,95,98,106,119,131,134,222,230,281],"the":[26,33,54,93,104,132,172,220,231,236,243,250,290],"most":[27],"complicated":[28],"human":[29,64],"activities.":[30],"Prior":[31],"to":[32,43,47,68,77,102,170,282],"initiation":[34],"a":[36,150,154,191],"program,":[37],"an":[38],"in-depth":[39],"analysis":[40],"\"what":[42],"do\"":[44],"\"how":[46],"do":[48],"it\"":[49],"must":[50],"be":[51,69,78,205,278],"conducted.":[52],"On":[53],"macro":[55],"level,":[56],"market":[57],"prospects,":[58],"capital":[59,124],"required,":[60],"assessment,":[62],"necessary":[63],"resources,":[65,101],"etc.":[66,268],"need":[67,76],"evaluated":[70],"critically.":[71],"For":[72],"execution,":[73],"drug":[74,135,202,223,245,297],"candidates":[75],"optimized":[79],"in":[80,108,117,162,194,207,252,299],"properties":[82],"such":[83,256],"as":[84,257],"potency,":[85],"selectivity,":[86],"pharmacokinetics,":[87],"safety,":[88],"formulation,":[89],"etc.,":[90],"all":[91,198],"with":[92,175],"constraint":[94],"finite":[96],"amount":[97],"time":[99],"maximize":[103],"probability":[105],"success":[107],"clinical":[109],"discovery":[112,165,203,224,246],"enormously":[114],"complicated,":[115],"terms":[118],"innovation":[121,298],"organizing":[123],"other":[126],"resources.":[127],"A":[128],"deep":[129],"understanding":[130],"complexity":[133],"our":[138],"competitive":[139],"edge":[140],"critical":[142],"for":[143,201,296],"success.":[144],"Our":[145],"unique":[146],"government-enterprise-academia":[147],"system":[148],"represents":[149],"distinct":[151],"advantage.":[152],"As":[153],"new":[155],"player,":[156],"we":[157],"have":[158,248],"not":[159],"heavily":[160],"invested":[161],"any":[163],"particular":[164],"paradigm,":[166],"which":[167,209,226],"allows":[168],"us":[169],"select":[171],"optimal":[173],"approach":[174],"little":[176],"organizational":[177],"burden.":[178],"Virtue":[179],"R&D":[180,213],"model":[181,241],"using":[182],"CROs":[183],"has":[184,227],"gained":[185],"momentum":[186],"lately":[187],"China":[189,234],"global":[192],"leader":[193],"CRO":[195],"market.":[196],"Essentially":[197],"support":[200],"can":[204,276],"found":[206],"China,":[208],"greatly":[210],"enables":[211],"domestic":[212],"efforts.":[214],"The":[215,239],"information":[216],"technology":[217],"revolution":[218],"ensures":[219],"globalization":[221],"knowledge,":[225],"bridged":[228],"much":[229],"gap":[232],"between":[233],"developed":[237],"countries.":[238],"blockbuster":[240],"target-centric":[244],"paradigm":[247],"overlooked":[249],"several":[253],"important":[254],"fields":[255],"injectable":[258],"drugs,":[259,261],"orphan":[260],"following":[263],"quality":[265],"therapeutic":[266],"leads,":[267],"Prejudice":[269],"against":[270],"covalent":[271],"ligands,":[272],"prodrugs,":[273],"nondrug-like":[274],"ligands":[275],"also":[277],"taken":[279],"advantage":[280],"find":[283],"novel":[284],"medicines.":[285],"article":[287],"will":[288],"discuss":[289],"current":[291],"challenges":[292],"future":[294],"opportunities":[295],"China.":[300]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2398865192","counts_by_year":[{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
